Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression

Journal of Nutritional Biochemistry

Volumn 26, Issue 12, 2015, Pages 1502-1508

  Liu, Huan ^a   Tian, Tian ^a   Qin, Shanchun ^a   Li, Wen ^a   Zhang, Xumei ^a   Wang, Xuan ^a   Gao, Yuxia ^a   Huang, Guowei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid peptide; APP PS1 mice; Folic acid; MicroRNA

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; FOLIC ACID; MICRORNA; MICRORNA 106A-5P; MICRORNA 200B-3P; MICRORNA 399-5P; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; BACE1 PROTEIN, MOUSE; PRESENILIN 1; SECRETASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; COGNITION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; IMMUNOHISTOCHEMISTRY; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ALZHEIMER DISEASE; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; COGNITIVE DEFECT; GENE EXPRESSION REGULATION; MALE; MAZE TEST; METABOLISM; TRANSGENIC MOUSE; TUMOR CELL LINE;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BRAIN; CELL LINE, TUMOR; COGNITION; COGNITION DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLIC ACID; FOLIC ACID DEFICIENCY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; PRESENILIN-1; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84983146543     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.07.020     Document Type: Article

References (33)

1. Gotz J., Ittner L.M., Schonrock N., Cappai R. An update on the toxicity of Abeta in Alzheimer's disease. Neuropsychiatr Dis Treat 2008, 4:1033-1042.
2. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008, 14:27-41.
3. Patel N., Hoang D., Miller N., Ansaloni S., Huang Q., Rogers J.T., et al. MicroRNAs can regulate human APP levels. Mol Neurodegener 2008, 3:10-15.
4. Liu C.G., Wang J.L., Li L., Xue L.X., Zhang Y.Q., Wang P.C. MicroRNA-135a and -200b, potential biomarkers for Alzheimer's disease, regulate β secretase and amyloid precursor protein. Brain Res 2014, 1583:55-64.
5. Long J.M., Ray B., Lahiri D.K. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. J Biol Chem 2014, 289:5184-5198.
6. Zhu H.C., Wang L.M., Wang M., Song B., Tan S., Teng J.F., et al. MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1. Brain Res Bull 2012, 88:596-601.
7. Fang M., Wang J., Zhang X., Geng Y., Hu Z., Rudd J.A., et al. The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. Toxicol Lett 2012, 209:94-105.
8. Zong Y., Wang H., Dong W., Quan X., Zhu H., Xu Y., et al. miR-29c regulates BACE1 protein expression. Brain Res 2011, 1395:108-115.
9. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008, 28:1213-1223.
10. Stover P.J. One-carbon metabolism-genome interactions in folate-associated pathologies. J Nutr 2009, 139:2402-2405.
11. Smach M.A., Jacob N., Golmard J.L., Charfeddine B., Lammouchi T., Ben Othman L., et al. Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol 2011, 65:270-278.
12. Troen A.M., Chao W.H., Crivello N.A., D'Anci K.E., Shukitt-Hale B., Smith D.E., et al. Cognitive impairment in folate-deficient rats corresponds to depleted brain phosphatidylcholine and is prevented by dietary methionine without lowering plasma homocysteine. J Nutr 2008, 138:2502-2509.
13. 12-deficient diet. Exp Gerontol 2010, 45:195-201.
14. Fuso A., Nicolia V., Cavallaro R.A., Ricceri L., D'Anselmi F., Coluccia P., et al. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol Cell Neurosci 2008, 37:731-746.
15. Kutay H., Bai S., Datta J., Motiwala T., Pogribny I., Frankel W., et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006, 99:671-678.
16. 12 and folate on cognition over time: results from one-year follow-up. Neurol Neurochir Pol 2009, 43:321-329.
17. Quadri P., Fragiacomo C., Pezzati R., Zanda E., Forloni G., Tettamanti M., et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004, 80:114-122.
18. Kao T.T., Chu C.Y., Lee G.H., Hsiao T.H., Cheng N.W., Chang N.S., et al. Folate deficiency-induced oxidative stress contributes to neuropathy in young and aged zebrafish - implication in neural tube defects and Alzheimer's diseases. Neurobiol Dis 2014, 71:234-244.
19. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002, 22:1752-1762.
20. Hallacoglu B., Sassaroli A., Fantini S., Troen A.M. Cerebral perfusion and oxygenation are impaired by folate deficiency in rat: absolute measurements with noninvasive near-infrared spectroscopy. J Cereb Blood Flow Metab 2011, 31:1482-1492.
21. Fuso A., Nicolia V., Pasqualato A., Fiorenza M.T., Cavallaro R.A., Scarpa S. Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiol Aging 2011, 32:187-199.
22. Fuso A., Nicolia V., Cavallaro R.A., Scarpa S. DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models. J Nutr Biochem 2011, 22:242-251.
23. Li W., Liu H., Yu M., Zhang X., Zhang M., Wilson J.X., et al. Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice. J Nutr Biochem 2015, 26:883-891.
24. Li W., Jiang M., Xiao Y., Zhang X., Cui S., Huang G. Folic acid inhibits tau phosphorylation through regulation of PP2A methylation in SH-SY5Y cells. J Nutr Health Aging 2015, 19:123-129.
25. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos L., Eckman C., et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 1994, 264:1336-1340.
26. Murray M.M., Bernstein S.L., Nyugen V., Condron M.M., TeplowD B., Bowers M.T. Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization. J Am Chem Soc 2009, 131:6316-6317.
27. Crivello N., Jones T.S., Hale B.S., Carey A., Roe A., Smith D., et al. Folate deficiency accelerates Alzheimers disease related pathology in APP/PS1 mice. FASEB J 2013, 27:1077-1078.
28. Luo H., Wu Q., Ye X., Xiong Y., Zhu J., Xu J., et al. Genome-wide analysis of miRNA signature in the APPswe/PS1δE9 mouse model of alzheimer's disease. PLoS One 2014, 9:e101725.
29. Dominguez D.I., Hartmann D., De Strooper B. BACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's disease. Neurodegener Dis 2004, 1:168-174.
30. Fukumoto H., Cheung B.S., Hyman B.T., Irizarry M.C. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 2002, 59:1381-1389.
31. Holsinger R.M., McLean C.A., Beyreuther K., Masters C.L., Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol 2002, 51:783-786.
32. Li R., Lindholm K., Yang L.B., Yue X., Citron M., Yan R., et al. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci U S A 2004, 101:3632-3637.
33. Chen L.M., Lin Z.Y., Zhu Y.G., Lin N., Zhang J., et al. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells. Eur J Pharmacol. 2012, 675:15-21.